1. Home
  2. TLSA vs FDSB Comparison

TLSA vs FDSB Comparison

Compare TLSA & FDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TLSA
  • FDSB
  • Stock Information
  • Founded
  • TLSA 2013
  • FDSB 1926
  • Country
  • TLSA United Kingdom
  • FDSB United States
  • Employees
  • TLSA N/A
  • FDSB N/A
  • Industry
  • TLSA Biotechnology: Pharmaceutical Preparations
  • FDSB
  • Sector
  • TLSA Health Care
  • FDSB
  • Exchange
  • TLSA Nasdaq
  • FDSB NYSE
  • Market Cap
  • TLSA 87.8M
  • FDSB N/A
  • IPO Year
  • TLSA 2000
  • FDSB N/A
  • Fundamental
  • Price
  • TLSA $1.51
  • FDSB $12.39
  • Analyst Decision
  • TLSA
  • FDSB
  • Analyst Count
  • TLSA 0
  • FDSB 0
  • Target Price
  • TLSA N/A
  • FDSB N/A
  • AVG Volume (30 Days)
  • TLSA 407.1K
  • FDSB 4.4K
  • Earning Date
  • TLSA 05-13-2025
  • FDSB 05-19-2025
  • Dividend Yield
  • TLSA N/A
  • FDSB N/A
  • EPS Growth
  • TLSA N/A
  • FDSB N/A
  • EPS
  • TLSA N/A
  • FDSB N/A
  • Revenue
  • TLSA N/A
  • FDSB $10,664,000.00
  • Revenue This Year
  • TLSA N/A
  • FDSB N/A
  • Revenue Next Year
  • TLSA N/A
  • FDSB N/A
  • P/E Ratio
  • TLSA N/A
  • FDSB N/A
  • Revenue Growth
  • TLSA N/A
  • FDSB N/A
  • 52 Week Low
  • TLSA $0.54
  • FDSB $9.85
  • 52 Week High
  • TLSA $1.91
  • FDSB $14.50
  • Technical
  • Relative Strength Index (RSI)
  • TLSA 62.62
  • FDSB N/A
  • Support Level
  • TLSA $1.22
  • FDSB N/A
  • Resistance Level
  • TLSA $1.78
  • FDSB N/A
  • Average True Range (ATR)
  • TLSA 0.17
  • FDSB 0.00
  • MACD
  • TLSA 0.04
  • FDSB 0.00
  • Stochastic Oscillator
  • TLSA 64.94
  • FDSB 0.00

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.

Share on Social Networks: